首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1441209

全球心臟帮浦设备市场规模、份额、成长分析、按产品类型、按适应症、按最终用户 - 产业预测，2023-2030 年

Global Heart Pump Device Market Size, Share, Growth Analysis, By Product Type(Ventricular assist devices, Intra-aortic balloon pumps ), By Indication(Bridge-to-transplant, Destination therapy ), By End-user - Industry Forecast 2023-2030

出版日期: 2024年02月19日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球心泵设备市场规模为20.9亿美元，从2023年的26.1亿美元成长到2031年的153亿美元，预测期内（2024-2031年）复合年增长率为24.77%。增长至2000万万美元。

全球心臟泵设备市场正在全球范围内经历显着增长。该报告涵盖了心臟泵设备市场价值链分析的详细资讯，并为製造商提供了竞争考察，以在预测期内获得竞争优势。这一市场成长的主要驱动力是全球心血管疾病盛行率的不断上升。随着心臟衰竭盛行率的持续上升，对心臟泵设备的需求显着增加，心臟泵设备在支持和维持严重心臟疾病患者的心臟功能方面发挥关键作用。人口老化加剧，更容易罹患心臟病，进一步促进了市场扩张。除了高疾病负担之外，心臟帮浦技术的进步也推动了市场的发展。心臟帮浦设备的尺寸较小、耐用性更高和功能增强等技术创新正在显着改善患者的治疗效果并推动更多的采用。例如，磁浮辅助人工心臟(VAD) 的开拓透过更好地支持衰弱的心臟同时降低併发症的风险，彻底改变了市场。心臟泵设备市场也看到机械循环支援设备的快速采用。随着晚期心臟衰竭患者数量的不断增加，对长期机械支援的需求变得非常重要。机械循环支援装置，包括辅助人工心臟装置 (VAD) 和全人工心臟 (TAH)，为等待心臟移植的患者或被认为不适合移植的患者提供了生命线。随着目的地治疗的日益接受，市场进一步扩大，其中机械循环支持装置成为合格移植的患者的永久解决方案。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

雅培实验室（美国）
美敦力公司（爱尔兰）
LivaNova PLC（英国）
柏林之心有限公司（德国）
SynCardia Systems, LLC（美国）
Abiomed, Inc.（美国）
Getinge AB（瑞典）
泰尔茂株式会社（日本）
泰利福公司（美国）
贾维克心臟公司（美国）
Fresenius Medical Care AG & Co. KGaA（德国）
凯隆有氧运动（英国）
CardiacAssist, Inc.（美国）
BiVACOR Inc.（澳洲）
Leviticus Cardio Ltd.（以色列）
CARMAT SA（法国）
FineHeart SA（法国）
迈尔瓦德（美国）
微创医疗科技有限公司 (中国)
TandemLife，LivaNova 公司（美国）

简介目录

Product Code: SQMIG35A2376

Global Heart Pump Device Market size was valued at USD 2.09 Billion in 2022 and is poised to grow from USD 2.61 Billion in 2023 to USD 15.32 Billion by 2031, at a CAGR of 24.77% during the forecast period (2024-2031).

The global heart pump device market is witnessing substantial growth on a global scale. Our report encompasses detailed information on the value chain analysis for the Heart Pump Device market, providing manufacturers with insights to gain a competitive edge over the projected period. The primary driving force behind this market growth is the increasing prevalence of cardiovascular diseases on a global scale. As the incidence of heart failure continues to rise, the demand for heart pump devices has seen a significant upswing, given their crucial role in supporting and maintaining heart function in patients with severe cardiac conditions. The expanding aging population, more susceptible to heart ailments, further contributes to the market's expansion. In addition to the high disease burden, advancements in heart pump technology have propelled the market forward. Innovations such as miniaturization, improved durability, and enhanced functionality of heart pump devices have substantially improved patient outcomes, fostering increased adoption. For instance, the development of magnetically levitated ventricular assist devices (VADs) has revolutionized the market by providing better support to weakened hearts while reducing the risk of complications. The heart pump device market is also witnessing a surge in the adoption of mechanical circulatory support devices. With the increasing prevalence of advanced heart failure cases, the demand for long-term mechanical support has become critical. Mechanical circulatory support devices, including ventricular assist devices (VADs) and total artificial hearts (TAHs), offer a lifeline to patients awaiting heart transplantation or those deemed unsuitable candidates for transplantation. The growing acceptance of destination therapy, where mechanical circulatory support devices serve as a permanent solution for patient's ineligible for transplant, has further expanded the market's reach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Heart Pump Device Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analysed to get the final quantitative and qualitative data.

Global Heart Pump Device Market Segmental Analysis

The global Heart Pump Device market can be segmented based on product type, indication, end-user, and region. Based on product type, the market can be divided into ventricular assist devices (VADs), intra-aortic balloon pumps (IABPs), total artificial heart (TAH). Based on indication, the market can be categorized into bridge-to-transplant (BTT), destination therapy (DT), bridge-to-recovery (BTR). Based on end-user, the market can be categorized into hospitals, cardiology centers, ambulatory surgical centres. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Heart Pump Device Market

Continuous innovation and ongoing advancements in heart pump technology have notably enhanced the performance and outcomes of these devices. Technological progress has given rise to the development of smaller, more durable, and more efficient heart pump devices, ultimately leading to improved patient comfort and an enhanced quality of life. A notable example is the introduction of magnetically levitated ventricular assist devices (LVADs), which has effectively reduced device-related complications and contributed to improved patient outcomes.

Restraints in the Global Heart Pump Device Market

Heart pump devices are intricate and advanced medical technologies, leading to high manufacturing and acquisition costs. The elevated expenses associated with heart pump devices present a substantial financial burden for patients, healthcare providers, and healthcare systems. Additionally, challenges arise from the limited reimbursement coverage for these devices in certain regions, creating obstacles for patients seeking access to these life-saving technologies.

Market Trends of the Global Heart Pump Device Market

Devices that are compatible with heart pump systems are engineered to work seamlessly, optimizing their performance and ensuring efficient functioning. For instance, advanced control units are capable of providing precise management of pump flow and parameters, contributing to enhanced patient outcomes. Similarly, power sources that are compatible can offer extended battery life and a reliable power supply, thereby minimizing interruptions related to the device. These compatible devices often come equipped with advanced monitoring and data management capabilities, enabling real-time remote monitoring. This capability allows healthcare professionals to track patient status and make more informed decisions.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Heart Pump Device Market by Product Type

Market Overview
Ventricular assist devices (VADs)
Intra-aortic balloon pumps (IABPs)
Total artificial heart (TAH)

Global Heart Pump Device Market by Indication

Market Overview
Bridge-to-transplant (BTT)
Destination therapy (DT)
Bridge-to-recovery (BTR)

Global Heart Pump Device Market by End-user

Market Overview
Hospitals
cardiology centers
ambulatory surgical centers

Global Heart Pump Device Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Berlin Heart GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SynCardia Systems, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abiomed, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jarvik Heart, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Medical Care AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Calon Cardio (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CardiacAssist, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BiVACOR Inc. (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Leviticus Cardio Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CARMAT SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FineHeart SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MyLVAD (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MicroPort Scientific Corporation (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TandemLife, a LivaNova company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments